BAXTER Compound Sodium Lactate Solution and 5% Glucose 1000mL injection AHB2074 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter compound sodium lactate solution and 5% glucose 1000ml injection ahb2074

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

SYNTHAMIN 17 Amino acid 10% without Electrolytes with Glucose 50% 1000mL injection AHB6998 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

synthamin 17 amino acid 10% without electrolytes with glucose 50% 1000ml injection ahb6998

baxter healthcare pty ltd - methionine, quantity: 2 g/l; valine, quantity: 2.9 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); isoleucine, quantity: 3 g/l; glycine, quantity: 5.15 g/l; tryptophan, quantity: 0.9 g/l; histidine, quantity: 2.4 g/l; alanine, quantity: 10.35 g/l; phenylalanine, quantity: 2.8 g/l; tyrosine, quantity: 200 mg/l; glucose, quantity: 250 g/l; threonine, quantity: 2.1 g/l; arginine, quantity: 5.75 g/l; leucine, quantity: 3.65 g/l; serine, quantity: 2.5 g/l; proline, quantity: 3.4 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; sodium metabisulfite; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

SYNTHAMIN 17 Amino acid 10% with Electrolytes and Glucose 50% 1000mL injection AHB6351 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

synthamin 17 amino acid 10% with electrolytes and glucose 50% 1000ml injection ahb6351

baxter healthcare pty ltd - arginine, quantity: 5.75 g/l; leucine, quantity: 3.65 g/l; sodium chloride, quantity: 0.59 g/l; glycine, quantity: 5.15 g/l; proline, quantity: 3.4 g/l; serine, quantity: 2.5 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); threonine, quantity: 2.1 g/l; glucose, quantity: 250 g/l; alanine, quantity: 10.35 g/l; dibasic potassium phosphate, quantity: 2.61 g/l; tryptophan, quantity: 0.9 g/l; phenylalanine, quantity: 2.8 g/l; histidine, quantity: 2.4 g/l; isoleucine, quantity: 3 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; sodium metabisulfite; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

SYNTHAMIN 17 Amino acid 10% with Electrolytes and Glucose 25% 1000mL injection AHB6350 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

synthamin 17 amino acid 10% with electrolytes and glucose 25% 1000ml injection ahb6350

baxter healthcare pty ltd - dibasic potassium phosphate, quantity: 2.61 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); magnesium chloride hexahydrate, quantity: 0.51 g/l; sodium acetate, quantity: 3.4 g/l; threonine, quantity: 2.1 g/l; isoleucine, quantity: 3 g/l; proline, quantity: 3.4 g/l; glucose, quantity: 125 g/l; alanine, quantity: 10.35 g/l; sodium chloride, quantity: 0.59 g/l; serine, quantity: 2.5 g/l; methionine, quantity: 2 g/l; phenylalanine, quantity: 2.8 g/l; glycine, quantity: 5.15 g/l; - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

BAXTER 0.224% POTASSIUM CHLORIDE and 5% GLUCOSE 1000mL injection AHB1174 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.224% potassium chloride and 5% glucose 1000ml injection ahb1174

baxter healthcare pty ltd - glucose, quantity: 50 g/l; potassium chloride, quantity: 2.24 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the potassium chloride in glucose (5%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of potassium and chloride ion concentrations. this is also an alternative route of administration for the patients who are unable to take potassium orally or if hypokalaemia is severe. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER 0.15% POTASSIUM CHLORIDE and 5% GLUCOSE 1L Injection BP AHB1134 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter 0.15% potassium chloride and 5% glucose 1l injection bp ahb1134

baxter healthcare pty ltd - glucose, quantity: 50 g/l; potassium chloride, quantity: 1.5 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the potassium chloride in glucose (5%) intravenous infusion is indicated for replenishing fluid losses, as an energy source and for restoration or maintenance of potassium and chloride ion concentrations. this is also an alternative route of administration for the patients who are unable to take potassium orally or if hypokalaemia is severe. it may be used as a vehicle of drug delivery where intravenous delivery is appropriate and the drug is compatible with this solution.

BAXTER Compound Sodium Lactate Solution and 5% Glucose 500mL injection AHB2073 Australia - engelsk - Department of Health (Therapeutic Goods Administration)

baxter compound sodium lactate solution and 5% glucose 500ml injection ahb2073

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

Glucose Sterop 500 mg/ml sol. perf. i.v. amp. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucose sterop 500 mg/ml sol. perf. i.v. amp.

laboratoires sterop sa-nv - glucose monohydraté 550 mg/ml - eq. glucose anhydre 500 mg/ml - solution pour perfusion - 500 mg/ml - glucose monohydraté 550 mg/ml - carbohydrates

Glucose Sterop 500 mg/ml sol. perf. i.v. amp. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucose sterop 500 mg/ml sol. perf. i.v. amp.

laboratoires sterop sa-nv - glucose monohydraté 550 mg/ml - eq. glucose anhydre 500 mg/ml - solution pour perfusion - 500 mg/ml - glucose monohydraté 550 mg/ml - carbohydrates

Glucose Sterop 500 mg/ml sol. perf. i.v. flac. Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glucose sterop 500 mg/ml sol. perf. i.v. flac.

laboratoires sterop sa-nv - glucose monohydraté 550 mg/ml - eq. glucose anhydre 500 mg/ml - solution pour perfusion - 500 mg/ml - glucose monohydraté 550 mg/ml - carbohydrates